Jiangsu Hengrui Medicine Co Ltd
Jiangsu Hengrui Pharmaceuticals Co.,Ltd, a pharmaceutical company, researches, develops, manufactures, and commercializes medicines to address unmet clinical needs in China and internationally. It develops medicines in the areas of oncology, metabolic and cardiovascular, immunological and respiratory, neuroscience, pain management, infectious, respiratory system, hematological, ophthalmology, and… Read more
Jiangsu Hengrui Medicine Co Ltd (600276) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.080x
Based on the latest financial reports, Jiangsu Hengrui Medicine Co Ltd (600276) has a cash flow conversion efficiency ratio of 0.080x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥4.81 Billion) by net assets (CN¥60.03 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Jiangsu Hengrui Medicine Co Ltd - Cash Flow Conversion Efficiency Trend (1999–2024)
This chart illustrates how Jiangsu Hengrui Medicine Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Jiangsu Hengrui Medicine Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Jiangsu Hengrui Medicine Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Workday Inc
NASDAQ:WDAY
|
0.066x |
|
Chugai Pharmaceutical Co. Ltd
PINK:CHGCF
|
0.064x |
|
HUATEI SECS.CO GDR S/10
F:206G
|
N/A |
|
FirstEnergy Corporation
NYSE:FE
|
0.060x |
|
Sampo OYJ
PINK:SAXPY
|
0.003x |
|
Verisk Analytics Inc
NASDAQ:VRSK
|
1.108x |
|
Amadeus IT Group S.A
PINK:AMADF
|
0.144x |
|
Coupang LLC
NYSE:CPNG
|
0.004x |
Annual Cash Flow Conversion Efficiency for Jiangsu Hengrui Medicine Co Ltd (1999–2024)
The table below shows the annual cash flow conversion efficiency of Jiangsu Hengrui Medicine Co Ltd from 1999 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥46.09 Billion | CN¥7.42 Billion | 0.161x | -13.55% |
| 2023-12-31 | CN¥41.03 Billion | CN¥7.64 Billion | 0.186x | +465.54% |
| 2022-12-31 | CN¥38.41 Billion | CN¥1.27 Billion | 0.033x | -72.23% |
| 2021-12-31 | CN¥35.57 Billion | CN¥4.22 Billion | 0.119x | +6.39% |
| 2020-12-31 | CN¥30.79 Billion | CN¥3.43 Billion | 0.111x | -27.17% |
| 2019-12-31 | CN¥24.94 Billion | CN¥3.82 Billion | 0.153x | +9.23% |
| 2018-12-31 | CN¥19.80 Billion | CN¥2.77 Billion | 0.140x | -12.30% |
| 2017-12-31 | CN¥15.94 Billion | CN¥2.55 Billion | 0.160x | -20.66% |
| 2016-12-31 | CN¥12.87 Billion | CN¥2.59 Billion | 0.201x | -8.41% |
| 2015-12-31 | CN¥10.36 Billion | CN¥2.28 Billion | 0.220x | +15.77% |
| 2014-12-31 | CN¥8.29 Billion | CN¥1.57 Billion | 0.190x | -7.40% |
| 2013-12-31 | CN¥6.66 Billion | CN¥1.36 Billion | 0.205x | +16.46% |
| 2012-12-31 | CN¥5.44 Billion | CN¥958.37 Million | 0.176x | +46.20% |
| 2011-12-31 | CN¥4.38 Billion | CN¥527.36 Million | 0.120x | +8.44% |
| 2010-12-31 | CN¥3.47 Billion | CN¥385.95 Million | 0.111x | -32.59% |
| 2009-12-31 | CN¥2.67 Billion | CN¥439.12 Million | 0.165x | +183.99% |
| 2008-12-31 | CN¥2.02 Billion | CN¥117.46 Million | 0.058x | -56.71% |
| 2007-12-31 | CN¥1.63 Billion | CN¥218.87 Million | 0.134x | -36.72% |
| 2006-12-31 | CN¥1.26 Billion | CN¥266.18 Million | 0.212x | +2.98% |
| 2005-12-31 | CN¥1.11 Billion | CN¥227.88 Million | 0.206x | -1.99% |
| 2004-12-31 | CN¥998.05 Million | CN¥209.41 Million | 0.210x | +38.53% |
| 2003-12-31 | CN¥903.35 Million | CN¥136.82 Million | 0.151x | +146.17% |
| 2002-12-31 | CN¥809.97 Million | CN¥49.84 Million | 0.062x | +305.99% |
| 2001-12-31 | CN¥757.99 Million | CN¥11.49 Million | 0.015x | -48.01% |
| 2000-12-31 | CN¥672.57 Million | CN¥19.61 Million | 0.029x | -86.02% |
| 1999-12-31 | CN¥162.54 Million | CN¥33.89 Million | 0.208x | -- |